{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:40:50Z","timestamp":1785516050421,"version":"3.56.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the efficacy and safety of esketamine in reducing postpartum pain and depression in patients undergoing cesarean delivery (CD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Web of Science, Embase, PubMed, and Cochrane Library were searched from the inception of each database up to September 2025 to select relevant studies. Randomized controlled trials (RCTs) that assessed the efficacy of esketamine for pain control in patients undergoing CD were selected. The outcomes included scores of postpartum pain, the incidence of depression after surgery, scores on the Edinburgh Postnatal Depression Scale, and the incidence of adverse events before and after surgery. The stability of the results and potential sources of heterogeneity were investigated by subgroup and sensitivity analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This meta-analysis included ten studies comprising 15 intervention groups. A total of 2218 individuals undergoing CD were involved. Compared with the control group, esketamine showed relatively favorable effects on controlling rest pain at 24\u00a0h (SMD = \u22120.42; 95% CI: \u22120.69 to \u22120.16; P &amp;lt; 0.00001; I\n                      <jats:sup>2<\/jats:sup>\n                      = 84%), movement-evoked pain (MEP) at 24\u00a0h (SMD = \u22120.68; 95% CI: \u22121.29 to \u22120.07; P &amp;lt; 0.00001; I\n                      <jats:sup>2<\/jats:sup>\n                      = 92%), rest pain at 48\u00a0h (SMD = \u22120.22; 95% CI: \u22120.38 to \u22120.06; P = 0.006; I\n                      <jats:sup>2<\/jats:sup>\n                      = 54%), and MEP at 48\u00a0h (SMD = \u22120.63; 95% CI: \u22121.07 to \u22120.20; P &amp;lt; 0.00001; I\n                      <jats:sup>2<\/jats:sup>\n                      = 85%). In contrast to the control group, EPDS scores in the esketamine group were lower (SMD = \u22120.21; 95% CI: \u22120.39 to \u22120.04; P = 0.02; I\n                      <jats:sup>2<\/jats:sup>\n                      = 45%). Subgroup analyses indicated that pregnant women aged over 30\u00a0years who received esketamine had a higher incidence of dizziness (RR = 2.08; 95% CI: 1.26 to 3.34; P = 0.004; I\n                      <jats:sup>2<\/jats:sup>\n                      = 64%). The quality of evidence was moderate for six outcomes, and low for three outcomes according to the GRADE assessment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>As a therapy for postoperative analgesia, esketamine shows relatively favorable efficacy in pain control and is associated with a lower risk of postpartum depression. However, this result is unstable. Furthermore, esketamine may increase the risk of dizziness in pregnant women aged over 30\u00a0years. Since all the experiments in this study are conducted in China, there are certain regional limitations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1708221","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:27:27Z","timestamp":1764570447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of esketamine for pain control after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"16","author":[{"given":"Tingyu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.3390\/ijms24031866","article-title":"The role of sex hormones in pain-related conditions","volume":"24","author":"Athnaiel","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"B4","first-page":"1069","article-title":"The effects of minimal-dose versus low-dose S-ketamine on opioid consumption, hyperalgesia, and postoperative delirium: a triple-blinded, randomized, active- and placebo-controlled clinical trial","volume":"82","author":"Bornemann-Cimenti","year":"2016","journal-title":"Minerva Anestesiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1752232024","DOI":"10.1523\/JNEUROSCI.1752-23.2024","article-title":"Neuronal and molecular mechanisms underlying chronic pain and depression comorbidity in the paraventricular thalamus","volume":"44","author":"Cui","year":"2024","journal-title":"J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1093\/pubmed\/fdac036","article-title":"Strengthening systematic reviews in public health: guidance in the cochrane Handbook for Systematic Reviews of Interventions, 2nd edition","volume":"44","author":"Cumpston","year":"2022","journal-title":"J. Public Health (Oxf)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/jpm15040161","article-title":"Patient experience with intranasal esketamine in treatment-resistant depression: insights from a multicentric Italian Study (REAL-ESKperience)","volume":"15","author":"Di Nicola","year":"2025","journal-title":"J. Pers. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1394787","DOI":"10.3389\/fpsyt.2024.1394787","article-title":"Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review","volume":"15","author":"Di Vincenzo","year":"2024","journal-title":"Front. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"17448069241239231","DOI":"10.1177\/17448069241239231","article-title":"Esketamine inhibits the c-Jun N-terminal kinase pathway in the spinal dorsal horn to relieve bone cancer pain in rats","volume":"20","author":"Duan","year":"2024","journal-title":"Mol. Pain"},{"key":"B8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/10408363.2022.2050182","article-title":"Evaluating thyroid function in pregnant women","volume":"59","author":"Geno","year":"2022","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jpain.2019.09.005","article-title":"The decline of endogenous pain modulation with aging: a meta-analysis of temporal summation and conditioned pain modulation","volume":"21","author":"Hackett","year":"2020","journal-title":"J. Pain"},{"key":"B11","first-page":"27","article-title":"Maternal cerebral hemodynamics in the supine hypotensive syndrome","volume":"79","author":"Ikeda","year":"1992","journal-title":"Obstet. Gynecol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41398-024-02796-0","article-title":"The endogenous opioid system in the medial prefrontal cortex mediates ketamine's antidepressant-like actions","volume":"14","author":"Jiang","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"B13","article-title":"Kvarta MD: Esketamine in depression: putative biomarkers from clinical research","author":"Johnston","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bja.2024.11.004","article-title":"A critical approach to research on perioperative pain management","volume":"134","author":"Joshi","year":"2025","journal-title":"Br. J. Anaesth."},{"key":"B15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12871-024-02436-6","article-title":"Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial","volume":"24","author":"Li","year":"2024","journal-title":"BMC Anesthesiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jad.2023.07.103","article-title":"Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: a randomized controlled trial","volume":"339","author":"Liu","year":"2023","journal-title":"J. Affect Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00737-014-0467-y","article-title":"Psychophysiology and posttraumatic stress disorder symptom profile in pregnant African-American women with trauma exposure","volume":"18","author":"Michopoulos","year":"2015","journal-title":"Arch. Womens Ment. Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1213\/ANE.0000000000004203","article-title":"Stroke in pregnancy: a focused update","volume":"130","author":"Miller","year":"2020","journal-title":"Anesth. Analg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"108.e1","DOI":"10.1016\/j.ajog.2021.07.007","article-title":"Trajectories of antenatal depression and adverse pregnancy outcomes","volume":"226","author":"Miller","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1213\/ANE.0000000000006851","article-title":"Esketamine: less drowsiness, more analgesia","volume":"139","author":"Mion","year":"2024","journal-title":"Anesth. Analg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"120231","DOI":"10.1016\/j.jad.2025.120231","article-title":"Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on treatment-resistant depression: findings from a prospective observational study","volume":"392","author":"Olivola","year":"2025","journal-title":"J. Affect Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jclinepi.2020.03.022","article-title":"Controversy and debate on Meta-epidemiology. Paper 4: confounding and other concerns in meta-epidemiological studies of bias","volume":"123","author":"Page","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jad.2024.06.080","article-title":"Perioperative esketamine administration for prevention of postpartum depression after the cesarean section: a systematic review and meta-analysis","volume":"361","author":"Parsaei","year":"2024","journal-title":"J. Affect Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1093\/cercor\/bhaa052","article-title":"Age-dependent changes in synaptic NMDA receptor composition in adult human cortical neurons","volume":"30","author":"Pegasiou","year":"2020","journal-title":"Cereb. Cortex"},{"key":"B26","doi-asserted-by":"publisher","first-page":"151221","DOI":"10.1016\/j.semperi.2020.151221","article-title":"Drugs in pregnancy: pharmacologic and physiologic changes that affect clinical care","volume":"44","author":"Pinheiro","year":"2020","journal-title":"Semin. Perinatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3760\/cma.j.cn431274-20220807","article-title":"Efficacy of esketamine on acute and chronic pain after cesarean section","volume":"4","author":"Qiankun","year":"2023","journal-title":"J. Chin. Physician"},{"key":"B28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/17425255.2020.1750598","article-title":"The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysis","volume":"16","author":"Schoretsanitis","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1038379","DOI":"10.3389\/fpsyt.2022.1038379","article-title":"The effect of low-dose esketamine on pain and post-partum depression after cesarean section: a prospective, randomized, double-blind clinical trial","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"120152","DOI":"10.1016\/j.jns.2022.120152","article-title":"Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence","volume":"434","author":"Subramanian","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"B31","first-page":"774","article-title":"A study of low-dose S-ketamine infusion as \u201cpreventive\u201d pain treatment for cesarean section with spinal anesthesia: benefits and side effects","volume":"78","author":"Suppa","year":"2012","journal-title":"Minerva Anestesiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"988392","DOI":"10.3389\/fsurg.2022.988392","article-title":"Epidural esketamine and morphine for postoperative analgesia after caesarean delivery: a pilot study","volume":"9","author":"Tang","year":"2022","journal-title":"Front. Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S2213-8587(18)30026-3","article-title":"The physiology of endocrine systems with ageing","volume":"6","author":"van den Beld","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"110071","DOI":"10.1016\/j.jclinane.2020.110071","article-title":"Perioperative intravenous S-ketamine for acute postoperative pain in adults: a systematic review and meta-analysis","volume":"68","author":"Wang","year":"2021","journal-title":"J. Clin. Anesth."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.2147\/DDDT.S380292","article-title":"Sufentanil combined with nalbuphine via patient-controlled intravenous Analgesia after cesarean section: a retrospective evaluation","volume":"16","author":"Wang","year":"2022","journal-title":"Drug Des. Devel Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e239321","DOI":"10.1001\/jamanetworkopen.2023.9321","article-title":"Efficacy and safety of esketamine for supplemental Analgesia during elective cesarean delivery: a randomized clinical trial","volume":"6","author":"Xu","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.2147\/DDDT.S460924","article-title":"Esketamine combined with dexmedetomidine to reduce visceral pain during elective cesarean section under combined spinal-epidural anesthesia: a double-blind randomized controlled Study","volume":"18","author":"Yang","year":"2024","journal-title":"Drug Des. Devel Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1708221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:27:28Z","timestamp":1764570448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1708221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":38,"alternative-id":["10.3389\/fphar.2025.1708221"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1708221","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"1708221"}}